Cefoxitin

Paul A. Pham, Pharm.D., Edina Avdic, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, Pharm.D., BCPS

INDICATIONS

Lower respiratory tract infections
- Including pneumonia and lung abscess
Urinary tract infections
Intra-abdominal infections
- Including peritonitis and intra-abdominal abscess (IDSA guidelines: mild-moderate community-acquired infections only)
Gynecologic infections
- Including endometritis, pelvic cellulitis and pelvic inflammatory disease
Septicemia caused by S. pneumoniae, S. aureus (MSSA), E. coli, Klebsiella species, and Bacteroides species including B. fragilis (author’s comment: not a first-line agent for anaerobes, should confirm susceptibility)
Bone and joint infections (author’s comment: for mild infections only)
Skin and skin-structure infections

Surgical prophylaxis (GI, abdominal hysterectomy, vaginal hysterectomy, Cesarean section)
Infections due to Mycobacterium abscessus, Mycobacterium fortuitum, Mycobacterium chelonae

There's more to see -- the rest of this topic is available only to subscribers.